Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7390813 Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents

Patent 7390813 was granted and assigned to Xenon Pharmaceuticals on June, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Patent abstract

Novel compounds useful in the treatment of, prevention of or protection against diseases and/or conditions related to metabolic syndrome and lipid metabolism, especially diseases of fatty acid and cholesterol metabolism, such as those mediated by stearoyl-CoA desaturase, are disclosed along with methods of employing said compounds for such uses.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7390813 Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo